- Home
- CMPX vs KNOP Comparison
CMPX vs KNOP Comparison
Compare CMPX & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- KNOP
- Stock Information
- Founded
- CMPX 2014
- KNOP 2013
- Country
- CMPX United States
- KNOP United Kingdom
- Employees
- CMPX N/A
- KNOP N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- KNOP Marine Transportation
- Sector
- CMPX Health Care
- KNOP Consumer Discretionary
- Exchange
- CMPX Nasdaq
- KNOP Nasdaq
- Market Cap
- CMPX 206.3M
- KNOP 213.1M
- IPO Year
- CMPX N/A
- KNOP 2013
- Fundamental
- Price
- CMPX $1.42
- KNOP $5.51
- Analyst Decision
- CMPX Strong Buy
- KNOP
- Analyst Count
- CMPX 3
- KNOP 0
- Target Price
- CMPX $7.67
- KNOP N/A
- AVG Volume (30 Days)
- CMPX 421.2K
- KNOP 101.5K
- Earning Date
- CMPX 11-12-2024
- KNOP 12-04-2024
- Dividend Yield
- CMPX N/A
- KNOP 1.89%
- EPS Growth
- CMPX N/A
- KNOP N/A
- EPS
- CMPX N/A
- KNOP N/A
- Revenue
- CMPX $850,000.00
- KNOP $299,790,000.00
- Revenue This Year
- CMPX N/A
- KNOP $7.66
- Revenue Next Year
- CMPX $610.48
- KNOP $1.75
- P/E Ratio
- CMPX N/A
- KNOP N/A
- Revenue Growth
- CMPX N/A
- KNOP 4.75
- 52 Week Low
- CMPX $0.77
- KNOP $4.94
- 52 Week High
- CMPX $2.34
- KNOP $9.11
- Technical
- Relative Strength Index (RSI)
- CMPX 41.28
- KNOP 32.07
- Support Level
- CMPX $1.44
- KNOP $5.36
- Resistance Level
- CMPX $1.58
- KNOP $5.98
- Average True Range (ATR)
- CMPX 0.12
- KNOP 0.23
- MACD
- CMPX -0.01
- KNOP -0.02
- Stochastic Oscillator
- CMPX 11.63
- KNOP 17.50
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.